Bakhidze E.V., Belyaeva A.V., Berlev I.V.
New approaches to staging and treatment of primary endometrial cancer
|
№1 / 2024
|
Sturov N.V., Popov S.V., Mikhailov A.A., Zhukov V.A.
Disturbance of the gut microbiota and its correction in patients with chronic prostatitis
|
№1 / 2024
|
Sinyakova L.A., Kosova I.V., Loran O.B., Barsegian V.A.
Guideline on acute cystitis (uncomplicated urinary tract infection) (ICD-10 code N30.0) for general practitioners
|
№1 / 2024
|
Milovanov S.S.
Clinical center type in predicting patient enrollment
|
№1 / 2024
|
Novikov A.I., Novikov Yu.A., Zubareva E.Yu., Okhlopkov V.A.
A case of pseudoxanthoma elasticus in a young woman
|
№1 / 2024
|
Kandrashkina Yu.A., Orlova E.A., Levashova O.A., Kostina E.M.
Filaggrin as a biomarker of exacerbation of atopic dermatitis during pregnancy
|
№1 / 2024
|
Perlamutrov Yu.N., Olkhovskaya K.B., Lyapon A.O.
Clinical effectiveness of early use of systemic antibacterial therapy for acne
|
№1 / 2024
|
Sobolev A.V., Ponomarenko G.N., Grigoriev S.G.
Medical and psychological rehabilitation of patients with functional asthenia: determinants of effectiveness
|
№1 / 2024
|
Vorob’eva O.V.
Correction of cognitive impairment associated with age-dependent cerebral microangiopathy after COVID-19 using the combination drug vinpocetine+piracetam: clinical case report
|
№1 / 2024
|
Azimova Yu.E., Skorobogatykh K.V., Osipova V.V., Korobkova D.Z., Mamkhegov E.Z., Galanina A.S., Guziy E.A., Frolova A.V.
Erenumab – an antimigraine drug: experience of use
|
№1 / 2024
|
Shiroky R.V., Zakaryaeva A.R., Murtazalieva D.M., Zolotov M.A., Yakovlev M.Yu., Kvitivadze N.G., Parfenov I.P., Fomin V.S.
VR-IC (virtual reality in intensive care) clinical trial protocol: a program for the prevention of delirium and complications of long-term ICU patients using virtual reality
|
№1 / 2024
|
Belskaya G.N., Lukashevich I.G.
Features of management of a patient with secondary progressive multiple sclerosis: a clinical case
|
№1 / 2024
|